- Home
- RGF vs CLDI Comparison
RGF vs CLDI Comparison
Compare RGF & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGF
- CLDI
- Stock Information
- Founded
- RGF 2016
- CLDI 2014
- Country
- RGF United States
- CLDI United States
- Employees
- RGF N/A
- CLDI N/A
- Industry
- RGF Packaged Foods
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RGF Consumer Staples
- CLDI Health Care
- Exchange
- RGF Nasdaq
- CLDI Nasdaq
- Market Cap
- RGF 8.3M
- CLDI 8.3M
- IPO Year
- RGF 2021
- CLDI N/A
- Fundamental
- Price
- RGF $0.35
- CLDI $1.19
- Analyst Decision
- RGF Hold
- CLDI Strong Buy
- Analyst Count
- RGF 1
- CLDI 3
- Target Price
- RGF $0.50
- CLDI $16.67
- AVG Volume (30 Days)
- RGF 1.3M
- CLDI 76.2K
- Earning Date
- RGF 11-08-2024
- CLDI 11-12-2024
- Dividend Yield
- RGF N/A
- CLDI N/A
- EPS Growth
- RGF N/A
- CLDI N/A
- EPS
- RGF N/A
- CLDI N/A
- Revenue
- RGF $156,379,000.00
- CLDI N/A
- Revenue This Year
- RGF $23.67
- CLDI N/A
- Revenue Next Year
- RGF N/A
- CLDI N/A
- P/E Ratio
- RGF N/A
- CLDI N/A
- Revenue Growth
- RGF 18.88
- CLDI N/A
- 52 Week Low
- RGF $0.21
- CLDI $0.96
- 52 Week High
- RGF $2.75
- CLDI $30.60
- Technical
- Relative Strength Index (RSI)
- RGF 46.02
- CLDI 55.36
- Support Level
- RGF $0.27
- CLDI $0.96
- Resistance Level
- RGF $0.39
- CLDI $1.22
- Average True Range (ATR)
- RGF 0.04
- CLDI 0.08
- MACD
- RGF 0.00
- CLDI 0.02
- Stochastic Oscillator
- RGF 45.00
- CLDI 85.19
About RGF The Real Good Food Company Inc.
The Real Good Food Company Inc is an high-growth, branded, health- and wellness-focused frozen food company. It develops, markets, and manufactures delicious and convenient comfort foods designed to be high in protein, low in sugar, and made from gluten- and grain-free ingredients that are intended to be sold in the health and wellness segment of the frozen food category. All of its revenue is derived from the United States.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.